
Surajit Chakrabartty
About Surajit Chakrabartty
Data last updated:
Surajit Chakrabartty is a Cfo at Medgenome Labs Limited (since 2014), Director at Genx Diagnostics Limited (since 2024) and Director at Trident Diagnostics & Healthcare Private Limited (since 2022), and holds 5 more current directorships. The companies operate in Healthcare, Financial Services and Life Sciences. The 8 current companies with reported revenue have a combined latest revenue of ₹516 Cr; the largest is Medgenome Labs Limited at ₹407 Cr (FY 2025). Earlier, Surajit Chakrabartty was a Director at Maggenome Technologies Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 01 Dec 2014 | 2013 | ₹407 Cr (FY 2025) | Active | |
| Director | 21 Aug 2024 | 2016 | ₹36.97 Cr (FY 2025) | Active | |
| Director | 20 May 2022 | 2016 | ₹27.99 Cr (FY 2025) | Active | |
| Director | 26 Jun 2023 | 2023 | ₹20.75 Cr (FY 2025) | Active | |
| Additional Director | 18 Nov 2025 | 2014 | ₹13.25 Cr (FY 2022) | Active | |
| Director | 10 Jun 2017 | 2015 | ₹6.63 Cr (FY 2025) | Active | |
| Director | 25 Jan 2024 | 2019 | ₹2.37 Cr (FY 2025) | Active | |
| Director | 13 Nov 2023 | 2023 | ₹95.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2024 | 2015 | ₹86.2 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Surajit Chakrabartty
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Surajit Chakrabartty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surajit Chakrabartty
Surajit Chakrabartty currently holds 8 directorships: Medgenome Labs Limited (Cfo, since 01 Dec 2014, revenue ₹407 Cr (FY 2025)); Genx Diagnostics Limited (Director, since 21 Aug 2024, revenue ₹36.97 Cr (FY 2025)); Trident Diagnostics & Healthcare Private Limited (Director, since 20 May 2022, revenue ₹27.99 Cr (FY 2025)); Prl Diagnostics Private Limited (Director, since 26 Jun 2023, revenue ₹20.75 Cr (FY 2025)); Green Cross Genetics Lab Private Limited (Additional Director, since 18 Nov 2025, revenue ₹13.25 Cr (FY 2022)); and 3 more.
Surajit Chakrabartty was first appointed on 01 Dec 2014 as Cfo at Medgenome Labs Limited. The most recent appointment on record is 18 Nov 2025 at Green Cross Genetics Lab Private Limited.
The 8 current companies of Surajit Chakrabartty that report revenue have a combined latest revenue of ₹516 Cr: Medgenome Labs Limited ₹407 Cr (FY 2025); Genx Diagnostics Limited ₹36.97 Cr (FY 2025); Trident Diagnostics & Healthcare Private Limited ₹27.99 Cr (FY 2025); Prl Diagnostics Private Limited ₹20.75 Cr (FY 2025); Green Cross Genetics Lab Private Limited ₹13.25 Cr (FY 2022); and 3 more.
Surajit Chakrabartty held 1 earlier board appointment: Maggenome Technologies Private Limited (Director, 01 Sep 2024 to 20 Aug 2025).
The current boards of Surajit Chakrabartty's companies include Mahesh Pratapneni (Medgenome Labs Limited), Navjeewan Jatinder Khosla (Medgenome Labs Limited), Prasad Bhagwan Shejale (Medgenome Labs Limited), Shankar Mahadevappa Prasad (Medgenome Labs Limited), Suryaprakasam Vedam Lakshmi Ramprasad (Medgenome Labs Limited), Suryaprakasam Vedam Lakshmi Ramprasad (Medgenome Labs Limited), among others.